Actively Recruiting
Serrantor OCT Study
Led by Cagent Vascular LLC · Updated on 2025-05-18
60
Participants Needed
2
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
TA prospective randomized control trial to evaluate the serration angioplasty effect in BTK arteries with varying degrees of calcified plaque.
CONDITIONS
Official Title
Serrantor OCT Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Rutherford clinical category 4-6 of the target limb
- Age of subjects is >18 years old
- Patients has given informed consent to participate in this study
You will not qualify if you...
- De novo or restenotic (without prior stent) stenosis (≥70%) or occlusion
- Target lesion is in the BTK arteries, including below the knee popliteal, tibioperoneal trunk, tibial, peroneal, and pedal arteries.
- Angiographic visual estimated reference vessel diameter is between 2.0 and 5.0 mm.
- Lesion length less than 220 mm
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Columbia University
New York, New York, United States, 10032
Actively Recruiting
2
Weill Cornell Medical
New York, New York, United States, 10065
Actively Recruiting
Research Team
F
Feeny
CONTACT
W
Wittwer
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here